| Biotechnology Industry | Healthcare Sector | Mr. Chaofeng Hao CEO | SSE Exchange | CNE100005NM2 ISIN |
| CN Country | 657 Employees | 12 Jun 2023 Last Dividend | 12 Jun 2023 Last Split | - IPO Date |
Jiangsu CoWin Biotech Co., Ltd. is a prominent entity in China's biotechnology sector, focusing on the research and development, manufacture, and commercialization of a wide range of biological products. Founded in 2010, the company has quickly established itself as a key player in the field, primarily catering to the burgeoning needs of molecular diagnostics and medical device products. With its headquarters in Taizhou, China, Jiangsu CoWin Biotech has dedicated itself to advancing the science of molecular diagnostics through innovative solutions and services, contributing significantly to the healthcare and scientific research industries domestically.
Jiangsu CoWin Biotech Co., Ltd. offers an extensive portfolio of products and services designed to meet the diverse needs of the healthcare and scientific research sectors: